Oxford University About the DTU › Home page
› Staff
› Conferences
› Publications
› Slides
› Webcasts
› Contact
› Find us

Software › HOMA Calculator
› Outcomes Model
› Risk Engine

Current Studies › ACE
  · Home page
  · Organisation
  · Protocol
  · Ancillary studies
  · Conferences
  · Publications
  · Slides

› EXSCEL
› TECOS
› Translational

Completed Studies › 4-T
› ADOPT
› AFORRD
› DREAM
› EDIT
› FHS
› ISAT
› LDS
› UKPDS
› UKPDS~PTM

Intranet Search
Oxford Clinical Trials Logo
CTU Logo
Acarbose Cardiovascular Evaluation ACE Logo

Home page

The Acarbose Cardiovascular Evaluation (ACE) trial is a double-blind, randomised, multi-centre, cardiovascular intervention study coordinated by the University of Oxford Diabetes Trials Unit (DTU).  It has been designed by Professors Rury Holman (Oxford University, UK), Hu Dayi (People's Hospital Peking University, China) and Pan Chang Yu (Chinese PLA General Hospital, Beijing, China).

ACE will be conducted in up to 150 hospitals in mainland China and Hong Kong commencing in 2008.  The trial aims to determine whether reducing post prandial glycaemia with acarbose can reduce cardiovascular-related morbidity and mortality in patients with established cardiovascular disease (CVD) or acute coronary syndrome (ACS) who also have impaired glucose intolerance (IGT). Patients will be followed for a minimum of 4 years with the results expected in 2016.

You can apply to be a clinical centre using this form.

News


Search news :

Prof Holman speaks about ACE trial at ADA conference

13-Jun-2012
News Image DTU Director Professor Rury Holman gave an invited talk at the first joint China Medical Tribune and American Diabetes Association (ADA) symposium - 'A Perspective on "Metabetes" from China' - in Philadelphia, USA on Saturday 9th June...
[Full article]

ACE is seeking ancillary study proposals...

22-Jul-2010
News Image ...
[Full article]

First National ACE Investigator Meeting

11-Oct-2009
News Image ...
[Full article]

First ACE patient enrolled 17th February 2009

19-Feb-2009
News Image ...
[Full article]

Ethics approval received for the Acarbose Cardiovascular Evaluation (ACE) trial

28-Oct-2008
News Image The ACE trial has received ethics approval from the Oxford Tropical Research Ethics Committee (OXTREC)...
[Full article]

Acarbose Cardiovascular Evaluation (ACE) trial launched

11-Apr-2008
News Image The Acarbose Cardiovascular Evaluation (ACE) trial was launched on Friday 11th April 2008 at the 10th South China International Congress of Cardiology in Guangzhou, China...
[Full article]

The ACE study is funded by Bayer HealthCare in an academic collaboration with the Diabetes Trials Unit.